Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
ath-1017 (6 trials)
ath-1020 (1 trial)
Alzheimer Disease (Phase 2)
Dementia (Phase 2)
Trials (7 total)
Trial APIs (2 total)